Shuyan Wei1, Erika Gonzalez Rodriguez2, Ronald Chang2, John B Holcomb2, Lillian S Kao2, Charles E Wade2. 1. Center for Translational Injury Research, University of Texas Health Science Center, Houston, TX; Department of Surgery, McGovern Medical School, University of Texas Health Science Center, Houston, TX. Electronic address: shuyan.wei@uth.tmc.edu. 2. Center for Translational Injury Research, University of Texas Health Science Center, Houston, TX; Department of Surgery, McGovern Medical School, University of Texas Health Science Center, Houston, TX.
Abstract
BACKGROUND: Endotheliopathy of trauma is characterized by breakdown of the endothelial glycocalyx. Elevated biomarkers of endotheliopathy, such as serum syndecan-1 (Synd-1) ≥ 40 ng/mL, have been associated with increased need for transfusions, complications, and mortality. We hypothesized that severely injured trauma patients who exhibit elevated Synd-1 levels shortly after admission have an increased likelihood of developing sepsis. STUDY DESIGN: We analyzed a subset of patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial who survived at least 72 hours after hospital admission, and we determined elevated Synd-1 levels (≥ 40 ng/mL) 4 hours after hospital arrival. Sepsis was defined a priori as meeting systemic inflammatory response criteria and having a known or suspected infection. Univariate analysis was performed to identify variables associated with elevated Synd-1 levels and sepsis. Significant variables at a value of p < 0.2 in the univariate analysis were chosen by purposeful selection and analyzed in a mixed effects multivariate logistic regression model to account for the 12 different study sites. RESULTS: We included 512 patients. Of these, 402 (79%) had elevated Synd-1 levels, and 180 (35%) developed sepsis. Median Synd-1 levels at 4 hours after admission were 70 ng/dL (interquartile range [IQR] 36 to 157 ng/dL) in patients who did not develop sepsis, and 165 ng/dL [IQR 67 to 336 ng/dL] in those who did (p < 0.001). Adjusting for treatment arm and site, multivariable analyses revealed that elevated Synd-1 status, Injury Severity Score (ISS), and total blood transfused were significantly associated with an increased likelihood of developing sepsis. CONCLUSIONS:Elevated Synd-1 levels 4 hours after admission in severely injured adult trauma patients who survived the initial 72 hours after hospital admission are associated with subsequent sepsis.
RCT Entities:
BACKGROUND:Endotheliopathy of trauma is characterized by breakdown of the endothelial glycocalyx. Elevated biomarkers of endotheliopathy, such as serum syndecan-1 (Synd-1) ≥ 40 ng/mL, have been associated with increased need for transfusions, complications, and mortality. We hypothesized that severely injured traumapatients who exhibit elevated Synd-1 levels shortly after admission have an increased likelihood of developing sepsis. STUDY DESIGN: We analyzed a subset of patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial who survived at least 72 hours after hospital admission, and we determined elevated Synd-1 levels (≥ 40 ng/mL) 4 hours after hospital arrival. Sepsis was defined a priori as meeting systemic inflammatory response criteria and having a known or suspected infection. Univariate analysis was performed to identify variables associated with elevated Synd-1 levels and sepsis. Significant variables at a value of p < 0.2 in the univariate analysis were chosen by purposeful selection and analyzed in a mixed effects multivariate logistic regression model to account for the 12 different study sites. RESULTS: We included 512 patients. Of these, 402 (79%) had elevated Synd-1 levels, and 180 (35%) developed sepsis. Median Synd-1 levels at 4 hours after admission were 70 ng/dL (interquartile range [IQR] 36 to 157 ng/dL) in patients who did not develop sepsis, and 165 ng/dL [IQR 67 to 336 ng/dL] in those who did (p < 0.001). Adjusting for treatment arm and site, multivariable analyses revealed that elevated Synd-1 status, Injury Severity Score (ISS), and total blood transfused were significantly associated with an increased likelihood of developing sepsis. CONCLUSIONS: Elevated Synd-1 levels 4 hours after admission in severely injured adult traumapatients who survived the initial 72 hours after hospital admission are associated with subsequent sepsis.
Authors: Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink Journal: Pflugers Arch Date: 2007-01-26 Impact factor: 3.657
Authors: Andreia Z Chignalia; Feliz Yetimakman; Sarah C Christiaans; Sule Unal; Benan Bayrakci; Brant M Wagener; Robert T Russell; Jeffrey D Kerby; Jean-Francois Pittet; Randal O Dull Journal: Shock Date: 2016-04 Impact factor: 3.454
Authors: Rebecca Halbgebauer; Christian K Braun; Stephanie Denk; Benjamin Mayer; Paolo Cinelli; Peter Radermacher; Guido A Wanner; Hans-Peter Simmen; Florian Gebhard; Daniel Rittirsch; Markus Huber-Lang Journal: J Crit Care Date: 2017-11-16 Impact factor: 3.425
Authors: Ronald Chang; John B Holcomb; Pär I Johansson; Shibani Pati; Martin A Schreiber; Charles E Wade Journal: Shock Date: 2018-01 Impact factor: 3.454
Authors: Peter C Hou; Michael R Filbin; Henry Wang; Long Ngo; David T Huang; William C Aird; Donald M Yealy; Derek C Angus; John A Kellum; Nathan I Shapiro Journal: Chest Date: 2017-01-19 Impact factor: 9.410
Authors: Ricky J Haywood-Watson; John B Holcomb; Ernest A Gonzalez; Zhanglong Peng; Shibani Pati; Pyong Woo Park; WeiWei Wang; Ana Maria Zaske; Tyler Menge; Rosemary A Kozar Journal: PLoS One Date: 2011-08-19 Impact factor: 3.240
Authors: Charlotte Mae K Waits; Aaron Bower; Kelli N Simms; Bradford C Feldman; Nathan Kim; Susan Sergeant; Floyd H Chilton; Pamela J VandeVord; Carl D Langefeld; Elaheh Rahbar Journal: J Neurotrauma Date: 2020-05-07 Impact factor: 5.269
Authors: Gabrielle E Hatton; Reginald E Du; Shuyan Wei; John A Harvin; Kevin W Finkel; Charles E Wade; Lillian S Kao Journal: J Am Coll Surg Date: 2019-11-14 Impact factor: 6.113
Authors: David M Burmeister; Tiffany C Heard; Tony Chao; Karl Alcover; Amanda Wagner; Kevin K Chung; Kevin S Akers Journal: Crit Care Explor Date: 2022-01-05
Authors: Derek J B Kleinveld; Derek D G Simons; Charlotte Dekimpe; Shannen J Deconinck; Pieter H Sloos; M Adrie W Maas; Jesper Kers; Joshua Muia; Karim Brohi; Jan Voorberg; Karen Vanhoorelbeke; Markus W Hollmann; Nicole P Juffermans Journal: Blood Adv Date: 2021-09-14
Authors: Heather R Kregel; Gabrielle E Hatton; Kayla D Isbell; Hanne H Henriksen; Jakob Stensballe; Per I Johansson; Lillian S Kao; Charles E Wade Journal: Shock Date: 2022-01-01 Impact factor: 3.533
Authors: Danielle S Gruen; Joshua B Brown; Francis X Guyette; Yoram Vodovotz; Pär I Johansson; Jakob Stensballe; Derek A Barclay; Jinling Yin; Brian J Daley; Richard S Miller; Brian G Harbrecht; Jeffrey A Claridge; Herb A Phelan; Matthew D Neal; Brian S Zuckerbraun; Timothy R Billiar; Jason L Sperry Journal: JCI Insight Date: 2020-04-23
Authors: Charalampos Pierrakos; Dimitrios Velissaris; Max Bisdorff; John C Marshall; Jean-Louis Vincent Journal: Crit Care Date: 2020-06-05 Impact factor: 9.097
Authors: Stefan W Leichtle; Anand K Sarma; Micheal Strein; Vishal Yajnik; Dennis Rivet; Adam Sima; Gretchen M Brophy Journal: Neurocrit Care Date: 2020-02 Impact factor: 3.210